Omnicell layoffs, on the record
Every job cut, severance charge and restructuring Omnicell reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 3,650 to approximately 3,580.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 3,650 | December 31, 2023 |
| 10-K for 2024 | approximately 3,670 | December 31, 2024 |
| 10-K for 2025 | approximately 3,580 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryCompany announced a restructuring initiative in November 2022 that reduced headcount as part of expense containment (the 2022 Plan).
Word for word“On November 23, 2022, the Company committed to a plan to reduce the Company's headcount ("the 2022 Plan") as part of the Company's expense containment efforts being implemented due to ongoing macroeconomic headwinds, primarily consisting of employee severance and benefits costs.” 10-K for 2023
Our summaryCompany continued the 2022 Plan in early 2023, further reducing headcount across many functions and reducing its real estate footprint.
Word for word“During the first quarter of 2023, as a result of continued exploration of expense containment measures, the Company committed to further reduce its headcount across many of its functions as a continuation of the 2022 Plan, and also committed to reduce its real estate footprint to align with its broader hybrid work strategy and in an effort to further reduce costs.” 10-K for 2023
Our summaryCompany committed to a new 2023 Plan to reduce headcount and real estate footprint, with severance costs incurred during 2023.
Word for word“On November 2, 2023, the Company committed to a plan to reduce the Company's headcount and real estate footprint (the "2023 Plan") as part of the Company's expense containment initiatives and other actions to reduce discretionary spending being implemented due to challenging industry dynamics and macroeconomic conditions.” 10-K for 2023
Our summaryCompany recorded impairment and abandonment charges on operating lease right-of-use assets tied to restructuring to reduce its real estate footprint.
Word for word“During the year ended December 31, 2023, the Company recorded impairment and abandonment charges to operating lease right-of-use assets of $ 10.0 million, in connection with restructuring activities to reduce its real estate footprint and for optimization of certain leased facilities.” 10-K for 2023
Our summaryCompany recorded an immaterial reversal of previously recognized restructuring expenses associated with the 2022 Plan.
Word for word“During the year ended December 31, 2023, the Company recorded an immaterial reversal of previously recognized restructuring expenses associated with the 2022 Plan.” 10-K for 2023
Our summaryRestructuring initiatives in 2022 included committing to a plan to reduce headcount for expense containment, with employee severance costs recorded.
Word for word“During the year ended December 31, 2022, the restructuring plans incurred $ 22.8 million of employee severance costs and related expenses.” 10-K for 2024
Our summaryExpense containment measures in 2023 included a reduction of headcount across many functions and a reduction of real estate footprint, with severance costs recorded net of reversals.
Word for word“During the year ended December 31, 2023, the restructuring initiatives incurred $ 15.5 million of employee severance costs and related expenses, net of reversals.” 10-K for 2024
Our summaryManagement committed to winding down the Medimat Robotic Dispensing System product line, with employee severance and other expenses incurred and a related inventory write-down.
Word for word“On April 26, 2024, the Company's management committed to the wind down of the Company's Medimat Robotic Dispensing System ("RDS") product line, subject to local law and statutory works council consultation requirements.” 10-K for 2024
Our summaryThe company wound down its Medimat Robotic Dispensing System product line and recorded severance and other costs in 2024.
Word for word“During the year ended December 31, 2024, the Company incurred approximately $ 6.6 million of employee severance costs and other expenses related to the RDS product line wind down, net of immaterial reversals of previously recognized restructuring expenses.” 10-K for 2025
Our summaryThe company recorded more severance and other costs in 2025 for the continuing wind down of the RDS product line.
Word for word“During the year ended December 31, 2025, the Company incurred approximately $ 3.9 million of employee severance costs and other expenses in connection with this initiative.” 10-K for 2025
Our summaryThe company restructured its EnlivenHealth business to improve efficiency and adapt to changes in retail pharmacy, incurring severance and related costs.
Word for word“During the year ended December 31, 2025, the Company incurred approximately $ 2.6 million of employee severance and other related expenses in connection with this initiative.” 10-K for 2025
| Fiscal year ended | Restructuring charges | Restructuring costs incurred | Cash paid for restructuring |
|---|---|---|---|
| 2016-12-31 | — | — | $1.7 million |
| 2017-12-31 | — | — | $4.2 million |
| 2020-12-31 | $10 million | — | — |
| 2021-12-31 | $2 million | — | — |
| 2022-12-31 | $22.8 million | $22.8 million | — |
| 2023-12-31 | $15.5 million | $15.5 million | — |
| 2024-12-31 | $5.2 million | $6.6 million | — |
| 2025-12-31 | $6.5 million | — | — |
Omnicell filed 5 restructuring notices (Form 8-K, Item 2.05) since 2016. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Omnicell’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.